New pain program aims to help underserved cancer survivors
NCT ID NCT06063603
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study tested a pain management program for cancer survivors living in rural areas or of Hispanic background. The program included acupuncture, cognitive behavior therapy, educational materials, and a pain clinic referral. The goal was to see if the program was feasible and acceptable to participants, with the hope of running a larger future trial.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Acupuncture, cognitive behavior therapy, educational materials, and pain clinic referral
- What this could lead to
- If successful, this could lead to a larger trial testing a practical pain management program that helps rural and Hispanic cancer survivors better control their pain.
- What could go wrong
- This is a small pilot study with only 51 participants, so results may not apply to everyone. The program combines several approaches, making it hard to know which part works best.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
51 people
The number who actually took part.
- Started
-
May 2023
- Finished
-
May 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * A qualifying liquid or solid cancer diagnosis with visits at a participating Mayo site * Age 18+ * Numerical rating scale (NRS) pain score of a 5+ out of 10 * Pain that developed (onset) or significantly worsened since cancer diagnosis * Malignant hematology including: * Lymphoma * Myeloma * Chronic leukemias Exclusion Criteria: * Patient Health Questionnaire (PHQ) 8 score of 10 or more * Life expectancy less than 12 months * Hospice enrollment * Admitted to hospital from long term care/skilled nursing facilities (SNF) * Acute leukemias * Primary brain tumors * Confinement to a bed or a chair more than a third of waking hours because of health complications
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic leukemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Bispecific antibody combo aims to deepen myeloma responses
- Can a stronger drug cocktail give older myeloma patients a better start?
- Mitochondria-Targeting drug gamitrinib tested for first time in humans
- Reprogrammed immune cells target CD30-Positive lymphoma in early trial
- Can an experimental pill boost cancer immunotherapy? early trial puts HG146 to the test
- Cheap blood count ratios eyed as window into Myeloma's inflammatory grip